BACKGROUND: We investigated the actions of propofol and isoflurane on nociceptive responses of neurons in the spinal cord. METHODS: We determined nociceptive responses of lumbar neurons in the dorsal horn (Ͻ1200 m) and ventral horn (Ͼ1200 m) of decerebrate rats before and during propofol (1 effective dose, ED 50 ) or isoflurane (1 minimum alveolar concentration) anesthesia. During recording of ventral horn neurons, we administered picrotoxin by infusion to determine whether isoflurane and propofol differed in their effects at the ␥ aminobutyric acid (GABA) Type A receptors. We also determined whether decerebration altered propofol requirements to produce immobility. RESULTS: Decerebration did not affect propofol requirements. The ED 50 for propofol was 497 Ϯ 58 g ⅐ kg Ϫ1 ⅐ min Ϫ1 in intact rats and 420 Ϯ 65 g ⅐ kg Ϫ1 ⅐ min Ϫ1 in decerebrated rats (P Ͼ 0.05), with corresponding propofol blood concentrations of 8.1 Ϯ 1.1 g/mL and 7.3 Ϯ 1.1 g/mL, respectively (P Ͼ 0.05). Propofol did not significantly depress dorsal horn neurons, but isoflurane depressed the responses to 56% of control (P Ͻ 0.05). Propofol depressed ventral horn neurons to 47% of control, whereas isoflurane depressed ventral horn neurons to 20% of control. Picrotoxin significantly reversed the depressant effect of propofol on ventral horn neuronal responses (79% of control, not significantly different from control). Picrotoxin, however, had no effect on isoflurane's depression of ventral horn neuronal responses (26% of control). CONCLUSIONS: Propofol acts in the spinal cord to produce immobility. This depressive effect occurs in the ventral horn and is mediated mainly by GABA A receptors. Isoflurane also depresses neurons in the ventral horn; however, isoflurane actions at the GABA A receptor are either weak or overridden by other effects in the ventral horn.
Immobi lity is an end point that is produced by all general anesthetics and is predominantly mediated by the spinal cord. 1,2 Sonner et al. 3 showed that the mechanism by which two commonly used anesthetics, propofol and isoflurane, cause immobility is different. The immobilizing effects of propofol, which acts at the GABA (␥ aminobutyric acid) Type A receptor, 4 -7 were antagonized in rats by picrotoxin, a noncompetitive GABA antagonist, whereas picrotoxin had lesser effects on immobility produced by isoflurane. 3 Anesthetics might mediate immobility at several anatomical locations within the central nervous system. Previous studies have shown significant depression of the dorsal horn by propofol and isoflurane, 8 -11 leading to the hypothesis that immobility could be the result of depression at the dorsal horn. In addition, anesthetics depress neurons in the ventral spinal cord, which includes motoneurons and central pattern generators, with the latter group of neurons being particularly sensitive to anesthetics. 10, 12 Propofol's sedative effect appears to occur via an action in the tuberomamillary nucleus in the hypothalamus 13 ; however, it is unclear whether propofol's immobilizing action occurs there, at another supraspinal site, or in the spinal cord. Therefore, we presently investigated whether the forebrain is critical to propofol-induced immobility by determining propofol requirements in decerebrate rats.
We also studied the effects of propofol and isoflurane on spinal neuronal responses to noxious stimulation. These studies were performed in decerebrate rats to exclude any contribution of supraspinal structures and to permit us to obtain control responses in the unanesthetized animal. We were therefore able to determine the full extent of anesthetic effect in the range from no anesthesia to that needed to produce immobility. We hypothesized that isoflurane and propofol would have a similar depressing effect on ventral horn neuronal activity and that the effect of propofol, but not isoflurane, would be significantly reversed by picrotoxin.
METHODS
The experimental protocol was approved by the University of California Davis Animal Use and Care Advisory Committee. Adult male Sprague-Dawley rats weighing 402-719 g were used for these experiments. We first determined the propofol effective dose requirements (ED 50 ) to prevent movement in 50% of animals in separate groups of intact and decerebrate rats. In another group of rats, we determined propofol and isoflurane effects on neuronal responses to noxious stimulation.
Propofol ED 50 Determination
The rats were anesthetized in a chamber with 4% isoflurane in oxygen followed by spontaneous mask ventilation with 2% isoflurane. We determined the propofol ED 50 in intact and decerebrated animals. All animals were monitored and prepared as described below (see Surgical and Neurophysiology Procedures section) with a tracheostomy tube, mechanical ventilation, a jugular line, 0.5 mg dexamethasone IV, a carotid line and a laminectomy at T13/L1. The animals in the decerebration group (n ϭ 7) underwent a carotid ligation of the contralateral side followed by craniectomy and decerebration. The control animals (n ϭ 8) underwent a craniectomy, but the brain was left intact. After a 1-h recovery time (equal for both decerebrated and nondecerebrated animals), a propofol infusion was started at either 480 g ⅐ kg Ϫ1 ⅐ min Ϫ1 (approximately 20% below the expected ED 50 ) or 720 g ⅐ kg Ϫ1 ⅐ min Ϫ1 (approximately 20% above the expected ED 50 ) for 30 min and isoflurane was turned off. The expected ED 50 (600 g⅐kg Ϫ1 ⅐min Ϫ1 ) was based on our prior data. 14 Animals were investigated in ascending (n ϭ 3 control, n ϭ 3 decerebrate) and descending (n ϭ 4 control, n ϭ 5 decerebrate) dose regimens. After a 30-min equilibration time, a 10-inch hemostat was applied to the tail and oscillated at 1 Hz for 1 min or until the animal displayed gross purposeful movement with pawing or turning of the head towards the stimulus. When a positive response occurred, a 2 mg/kg propofol bolus was administered and the infusion rate increased to approximately 20% above the prior infusion rate. After a 15-min equilibration time, the stimulus was repeated. When a negative response occurred, the infusion was stopped for 5 min and restarted at approximately 20% below the prior infusion rate and allowed to equilibrate for 15 min before retesting. Before each application of the tail pinch, a blood sample (0.25 mL) was collected from the carotid line and analyzed for propofol concentration using gas chromatography as previously described. 15 The propofol concentrations associated with the lowest infusion that prevented movement and the highest infusion that produced movement were averaged to obtain the propofol effective concentration (EC 50 ) associated with the ED 50 producing immobility.
Surgical and Neurophysiology Procedures
Rats were anesthetized with isoflurane in a chamber as described above. After tracheostomy tube placement (12 gauge), positive-pressure ventilation was initiated with a pump ventilator (Harvard Apparatus, Holliston, MA) at a rate and tidal volume that maintained end-expiratory carbon dioxide between 30 and 40 mm Hg as monitored by a calibrated Ohmeda Rascal II gas analyzer (Ohmeda, Salt Lake City, UT). The body temperature was measured with a rectal temperature probe and maintained between 36.5°C and 38°C with a water heated blanket. One jugular vein was cannulated with PE 50 tubing. One carotid artery was ligated, whereas the other carotid artery was cannulated with PE 50 tubing for arterial blood pressure monitoring (PB240; Tyco PB, Pleasanton, CA) and blood sampling. The lumbar spinal cord of T13 and L1 was exposed by laminectomy.
Dexamethasone (0.5 mg) was administered IV to reduce swelling of the brainstem after decerebration. 12 Dexamethasone does not affect spinal neuronal responses to noxious stimulation. 16 One hour after administration of the dexamethasone, the animal underwent a craniectomy to permit decerebration. The cerebral hemispheres were aspirated to expose the superior colliculi. A precollicular transection was performed with a surgical blade inserted at a 10 degree angle (angled posteriorly), and the remaining forebrain structures were removed by aspiration. Hemostasis was achieved with Surgicel (Ethicon, Cincinnati, OH) and Gelfoam (Pfizer, New York, NY) pledgets. Saline or hetastarch were infused to replace blood loss, and isoflurane administration was discontinued. The mean arterial blood pressure was maintained at 90 Ϯ 35 mm Hg (mean, standard deviation) throughout the experiments.
After recovery from the decerebration (usually 1 h or more), as demonstrated by limb movements in response to tail clamping, the animal received pancuronium bromide IV (0.3-0.4 mg/h; Baxter, Deerfield, IL) for muscle relaxation. The animal was then placed in a stereotaxic frame (Kopf, Tujunga, CA). The cord was stabilized by vertebral clamps on the vertebral bodies of T12 and L2, and the head was secured by ear bars and an incisor bar. The spinal dura was removed, and the exposed cord was covered with warm agar. A Teflon-coated tungsten microelectrode (8 -11 M⍀; FHC, Bowdoinham, ME) was then advanced into the lumbar spinal cord with a hydraulic microdrive (Kopf Instruments, Tujunga, CA). The action potentials were amplified (Tucker-Davis, Alachua, FL) and filtered (band pass 300 -5000 Hz). The signals were displayed by conventional means and transmitted to a computer for recording with a Powerlab interface and Chart software (AD Instruments, Grand Junction, CO) and for off-line spike discrimination and analysis. A minimum signal-to-noise ratio of 4 was standard.
We searched for extracellular action potentials using tactile stimulation of the hindpaw. We isolated action potentials from neurons at 200 -1200 m and 1200 -1800 m depth in the spinal cord. Depth was estimated from the microdrive readings. We focused on neurons that responded to hindpaw pinch within the L3-5 dermatomes. Most neurons were wide dynamic range neurons in that they responded to innocuous (brush) and noxious (pinch) mechanical stimuli with increasing firing rate, whereas a minority were nociceptive specific in that they only responded to noxious stimuli. The noxious stimulus was a standardized 5-s forceps pinch at steady intensity as previously described. 10 A small forceps was used which had been instrumented with a force transducer at the proximal end of the forceps. The force was maintained constant using the readout of the force transducer (Sensotec, Columbus, OH). The pinch force intensity necessary for maximal stimulation was established for each cell (between 50 and100 N) and was used at that level during pinching for each individual neuron.
Data Collection
In one set of experiments, we studied the response of dorsal horn neurons (Ͻ1200 m deep) to paw pinch without anesthetic (i.e., control), at either 1.3% isoflurane (i.e., 1 minimum alveolar concentration [MAC]) or 1 ED 50 propofol (i.e., 2 mg/kg propofol bolus plus a 600 g ⅐ kg Ϫ1 ⅐ min Ϫ1 propofol infusion with 30 min equilibration time). We studied a larger number of neurons in the propofol/dorsal horn group to insure that we did not miss a depressant effect of propofol. A power analysis revealed that we needed at least 21 neurons to detect a 15% or larger change in neuronal responses (␣ ϭ 0.05, ␤ ϭ 0.8).
In the second set of experiments, we determined nociceptive responses of neurons in the ventral horn (Ͼ1200 m). We obtained nociceptive responses during control conditions (i.e., without anesthesia) and then during propofol (1 ED 50 ) or isoflurane (1 MAC) anesthesia as described above. After this, we concurrently administered picrotoxin (200 g ⅐ kg Ϫ1 ⅐ min Ϫ1 for 30 min equilibration time) and obtained nocieptive responses again. The picrotoxin dose was chosen because this dose produced an approximately 150% increase in propofol requirements based on the data of Sonner et al. 3 When we initially tried a higher picrotoxin dose (400 g ⅐ kg Ϫ1 ⅐ min Ϫ1 ), the spinal cord neurons became so activated that the evaluation of a single neuron became virtually impossible. After completion of the experiment, the animals were killed by additional anesthetic and IV potassium chloride solution.
Data Analysis and Statistical Analysis
Neuronal activity was evaluated by counting the number of action potentials for 30 s before the pinch (spontaneous activity), during the 5-s pinch time (evoked activity) and 60 s after the start of the noxious pinch. The data were normalized to the control responses, i.e., the responses during anesthesia and anesthesia plus picrotoxin were divided by the control (anesthetic free) response. Data are presented as mean and standard error. The Student's t-test or repeated measures analysis of variance was used for statistical comparisons as appropriate. We also performed linear correlation between neuronal depth in spinal cord and the effect of isoflurane and propofol on the neuronal response to noxious stimulation. A P value of Ͻ0.05 was considered significant.
RESULTS
The ED 50 for propofol was 497 Ϯ 58 g ⅐ kg Ϫ1 ⅐ min Ϫ1 in intact rats and 420 Ϯ 65 g ⅐ kg Ϫ1 ⅐ min Ϫ1 in decerebrate rats (P Ͼ 0.05), with corresponding propofol blood levels of 8.1 Ϯ 1.1 g/mL and 7.3 Ϯ 1.1 g/mL, respectively (P Ͼ 0.05). Individual propofol blood levels are shown in Figure 1 .
Neuronal responses were recorded from 62 neurons in 57 rats. Recordings were made from 11 dorsal horn neurons (depth: 538 Ϯ 57 m) and 14 ventral horn neurons (1569 Ϯ 65 m) for the isoflurane group and 23 dorsal horn (490 Ϯ 38 m) and 14 ventral horn neurons (1563 Ϯ 58 m) for the propofol group.
Average nociceptive responses in the absence of anesthesia (i.e., control) for the isoflurane groups (dorsal horn and ventral horn groups) and the propofol groups (dorsal horn and ventral horn groups) ranged from 283 Ϯ 35 to 509 Ϯ 54 impulses/5 s (Table  1) . Spontaneous activity is shown in Table 2 . Figures 2  and 3 show raw examples of action potentials recorded from ventral horn neurons in the absence of anesthesia, during propofol ( Fig. 2 ) and isoflurane anesthesia (Fig. 3) , and with picrotoxin.
Dorsal horn cells were not depressed by propofol (86% Ϯ 8% of control, P Ͼ 0.05) but were significantly depressed by isoflurane (to 56% Ϯ 10% of control, P ϭ 0.002; Fig. 4 ). Ventral horn cells were significantly depressed by both propofol (47% Ϯ 10% of control, P Ͻ 0.0001) and isoflurane (20% Ϯ 8% of control, P Ͻ 0.0001; Fig. 5 ).
Isoflurane depressed both the dorsal and ventral cord significantly more than did propofol ( Figs. 4 and 5) .
The infusion of picrotoxin at 200 g ⅐ kg Ϫ1 ⅐ min Ϫ1 reversed the effects of propofol on the ventral horn neurons with responses increasing from 47% Ϯ 10% of control to 79% Ϯ 12% of control, P Ͻ 0.05; the latter value was not statistically significantly different from the control response. Picrotoxin did not reverse the effect of isoflurane anesthesia inasmuch as the ventral horn neurons were still significantly depressed (26% Ϯ 7% of control; P value of Ͻ0.0001, but not significantly different from prepicrotoxin value; Fig. 4 ).
There was a significant linear correlation between neuronal depth in the spinal cord and the effect of isoflurane and propofol on neuronal responses to noxious stimulation. Figure 6 shows that neurons in the ventral horn were more likely to be depressed by isoflurane ( Fig. 6A) or propofol (Fig. 6B ).
DISCUSSION
The main findings of this study were that 1) propofol acts in the spinal cord to produce immobility; 2) isoflurane, but not propofol, depressed dorsal horn neuronal responses to noxious stimulation; 3) propofol and isoflurane depressed ventral horn neurons, with isoflurane having the greater depressive effect; and 4) picrotoxin reversed (to approximately 80% of control) propofol's depression of ventral horn neurons, whereas it had no significant effect on isoflurane's depression of ventral horn neurons. We discuss these findings relative to the proposed mechanisms and sites of anesthetic-induced immobility. Although we have previously investigated effects of isoflurane and propofol on neuronal responses in the dorsal and ventral aspects of the spinal cord, 10 the findings that propofol acts in spinal cord to produce immobility are novel, as are the data showing that picrotoxin reverses propofol's depressant effect on ventral horn neurons.
The sedative and immobilizing actions of propofol appear to act at different anatomic sites. Nelson et al. 13 showed that propofol's sedative effect resulted from action in the tuberomammillary nucleus of the hypothalamus, part of the arousal-sleep pathway. The present data indicate that decerebration does not affect propofol requirements, thus suggesting a spinal site of action vis-à-vis immobility. This is consistent with the actions of some inhaled anesthetics, such as isoflurane and halothane. 1, 2, 17 Although the spinal cord is the primary site where anesthetics produce immobility, it was unclear where in the spinal cord this action occurred. Focus was initially placed on the dorsal horn; however, recent evidence suggests that neurons in the ventral horn are a more likely critical target. 10 We presently determined that propofol did not significantly depress neurons in the dorsal horn, but this was not true for isoflurane. Propofol's lack of effect in the dorsal horn turned our attention to the ventral horn. Neurons in this spinal cord area include central pattern generators and motoneurons. Data from our laboratories indicate that ventral horn neurons are more sensitive to anesthetics in the peri-MAC range compared with dorsal Mean and standard error of control (anesthetic-free) spontaneous activity (5 s). Spontaneous activity was determined in the preceding 30 s and divided by 6 to obtain average spontaneous activity for a 5-s period. *P Ͻ 0.05 compared with dorsal horn value for propofol and ventral horn value for isoflurane.
horn neurons and that central pattern generators are the likely neurons where anesthetics produce immobility. 10, 12 Data from the present study are consistent with this scenario. In our prior study, we gave propofol as a bolus to isoflurane-anesthetized animals, 10 so we could not exclude an interaction between isoflurane and propofol nor could we discount the possibility that bolus administration resulted in high plasma concentrations that were well above those needed to produce immobility and that depressed dorsal horn neurons. These two factors were absent in the present study. We have previously found that bolus administration of propofol to the torso circulation depressed dorsal horn responses at propofol blood levels similar to those presently obtained. 8 In that study, however, propofol was administered during baseline isoflurane anesthesia, so it is possible that the observed depression was due to the combination of the two drugs. 8 Our finding that propofol's depressive effect is reversed by picrotoxin is not surprising given that mutation of the ␤-3 subunit of the GABA A receptor produces resistance to propofol. 4 We were presently interested in whether picrotoxin's reversal of propofoland isoflurane-induced depression of spinal neuronal responses mirrored the effect of picrotoxin on the ED 50 for immobility. Sonner et al. 3 found that picrotoxin (at doses used in the present study) produced an approximately 150% increase in propofol ED 50 , whereas it produced a 50% increase in isoflurane MAC. We found that picrotoxin increased spinal nociceptive responses by approximately 100% during propofol anesthesia, whereas it produced a 20% numerical (but statistically insignificant) increase in neuronal responses during isoflurane anesthesia, a more than threefold difference between the two anesthetics.
Interestingly, Alvarez et al. 18 reported that the ␤-3 subunit of the GABA A receptor is found in the dorsal horn and ventral horn but not on motoneurons. How can those data be reconciled with our findings that propofol had no effect on dorsal horn neuronal responses but decreased responses in the ventral horn? We speculate that network properties in the spinal cord might partly explain this discrepancy. Ventral horn neurons receive convergent synaptic input from neurons at multiple levels of the spinal cord, imparting these neurons with large whole-body receptive fields, making Propofol and isoflurane were administered at 1 effective dose 50% (ED 50 ) and 1 minimum alveolar concentration (MAC). Note that the depression by propofol is minimal (P ϭ NS), whereas the depression by isoflurane is significant (*P Ͻ 0.05). Figure 5 . Ventral horn neuronal responses during the 5-s pinch stimulus as fraction of control responses during propofol (PPF) and isoflurane (Iso) anesthesia and with picrotoxin (Picro). Propofol and isoflurane were administered at 1 effective dose 50% (ED 50 ) and 1 minimum alveolar concentration (MAC). Picrotoxin was administered at 200 g ⅐ kg Ϫ1 ⅐ min Ϫ1 . Note that isoflurane and propofol both depressed these neurons (*P Ͻ 0.01, #P Ͻ 0.01), although isoflurane caused more depression. Also, picrotoxin reversed the depression produced by propofol (•P Ͻ 0.05), but it had no effect on isoflurane's depression. them more susceptible to inhibition. Dorsal horn neurons, however, have small excitatory receptive fields, a situation likely because of the abundant GABA A receptors that produce inhibition of surrounding neurons (thereby increasing point discrimination). The finding that there are few or no ␤-3 subunits on motoneurons suggests that propofol depression in the ventral horn might occur at premotor interneurons.
In another study, Grasshoff and Antkowiak 19 found that sevoflurane and propofol acted at glycine and GABA A receptors. These investigators used a reduced preparation, i.e., cultured spinal cord slices from embryonic rats, which makes it difficult to directly compare their data with ours. Changes in receptor expression and subtype during development and/or culture or changes in anesthetic immobilizing requirements in slices versus intact networks could all conceivably contribute to differences between our data and those obtained from in vitro preparations. The present study has the advantage to examine neuronal changes that occur around a known behavioral end point (immobility) in intact spinal networks. Indeed, there is evidence that anesthetic-induced immobility is largely determined by effects on spinal locomotor networks, 12, 20 which are distributed and are necessarily disrupted in slice preparations.
There are some limitations to the present study. We did not determine isoflurane MAC in decerebrate rats as we did with propofol. We have previously observed that isoflurane MAC is unchanged after decerebration, 12 and Rampil et al. 1 have published similar results. Thus, we believe that we used isoflurane concentrations equipotent to the propofol dose. Nonetheless, we cannot exclude the possibility that decerebration might have removed sites critical to action of propofol and isoflurane. Lastly, we recorded from neurons that responded to noxious stimulation, but we did not further characterize these neurons, i.e., these neurons could have been part of central pattern generators, interneurons, or motoneurons.
In summary, we found that propofol acts in the spinal cord to produce immobility. Furthermore, neurons in the ventral horn are more sensitive to propofol than neurons in the dorsal horn. This depressant effect appears to occur by an action at the GABA A receptor. 
